Abstract
Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Lambert-Eaton Myasthenic Syndrome, Date of authorisation: 23/12/2009, Revision: 17, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have